Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 325,000 | 1,925,000 | 1,947,000 | 2,675,000 | 2,016,000 |
| Receivables | 1,866,000 | 1,778,000 | 1,669,000 | 1,675,000 | 1,631,000 |
| Inventories | 1,736,000 | 1,610,000 | 1,603,000 | 1,430,000 | 1,407,000 |
| Other current assets | 889,000 | 799,000 | 793,000 | 776,000 | 855,000 |
| TOTAL | $5,065,000 | $6,317,000 | $6,229,000 | $6,758,000 | $6,101,000 |
| Non-Current Assets | |||||
| PPE Net | 2,265,000 | 2,252,000 | 2,109,000 | 2,082,000 | 2,053,000 |
| Intangibles | 19,530,000 | 18,109,000 | 18,047,000 | 16,662,000 | 16,859,000 |
| Other Non-Current Assets | 5,477,000 | 5,552,000 | 5,493,000 | 5,665,000 | 5,887,000 |
| TOTAL | $27,272,000 | $25,913,000 | $25,649,000 | $24,409,000 | $24,799,000 |
| Total Assets | $32,337,000 | $32,229,000 | $31,877,000 | $31,168,000 | $30,900,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 238,000 | 261,000 | 261,000 | 262,000 | 13,000 |
| Accounts payable and accrued liabilities | 696,000 | 794,000 | 674,000 | 689,000 | 615,000 |
| Accrued Expenses | 2,306,000 | 2,436,000 | 2,418,000 | 2,442,000 | 2,060,000 |
| Other current liabilities | 1,034,000 | 783,000 | 669,000 | 680,000 | 705,000 |
| TOTAL | $4,275,000 | $4,274,000 | $4,022,000 | $4,073,000 | $3,393,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,067,000 | 8,804,000 | 8,824,000 | 8,847,000 | 9,082,000 |
| Other Non-Current Liabilities | 2,000,000 | 2,220,000 | 2,296,000 | 2,190,000 | 2,370,000 |
| TOTAL | $11,328,000 | $11,334,000 | $11,394,000 | $11,152,000 | $11,788,000 |
| Total Liabilities | $15,603,000 | $15,607,000 | $15,416,000 | $15,226,000 | $15,181,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,429,571 | 1,426,725 | 1,424,993 | 1,423,853 | 1,420,911 |
| Common Shares | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 |
| Retained earnings | -1,296,000 | -1,392,000 | -1,473,000 | -1,878,000 | -2,050,000 |
| Other shareholders' equity | 222,000 | 262,000 | 239,000 | 237,000 | 253,000 |
| TOTAL | $16,735,000 | $16,622,000 | $16,462,000 | $15,942,000 | $15,719,000 |
| Total Liabilities And Equity | $32,338,000 | $32,229,000 | $31,878,000 | $31,168,000 | $30,900,000 |